GeneDx Holdings Corp. (WGS) Selling and Marketing Expense USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
GeneDx Holdings Corp. quarterly/annual Selling and Marketing Expense history and growth rate from 2020 to 2024.
  • GeneDx Holdings Corp. Selling and Marketing Expense for the quarter ending March 31, 2024 was $16.1 M, a 19.6% increase year-over-year.
  • GeneDx Holdings Corp. Selling and Marketing Expense for the twelve months ending March 31, 2024 was $63.6 M, a 42.1% decline year-over-year.
  • GeneDx Holdings Corp. annual Selling and Marketing Expense for 2023 was $61 M, a 50.1% decline from 2022.
  • GeneDx Holdings Corp. annual Selling and Marketing Expense for 2022 was $122 M, a 8.28% increase from 2021.
  • GeneDx Holdings Corp. annual Selling and Marketing Expense for 2021 was $113 M, a 78.4% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $63.6 M $16.1 M +$2.63 M +19.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-29
Q4 2023 $61 M $15.6 M -$13.7 M -46.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $74.6 M $16.8 M -$17.6 M -51.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $92.3 M $15.2 M -$17.6 M -53.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $110 M $13.5 M -$12.2 M -47.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-29
Q4 2022 $122 M $29.2 M -$1.41 M -4.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $123 M $34.4 M +$6.23 M +22.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $117 M $32.8 M +$14.3 M +76.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $103 M $25.6 M -$9.74 M -27.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $113 M $30.6 M +$6.71 M +28% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-14
Q3 2021 $106 M $28.2 M +$12.9 M +84.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $93.1 M $18.6 M +$8.41 M +82.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $84.7 M $35.4 M +$21.5 M +156% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $63.2 M $23.9 M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $15.2 M Jul 1, 2020 Sep 30, 2020 10-K 2022-03-14
Q2 2020 $10.2 M Apr 1, 2020 Jun 30, 2020 10-K 2022-03-14
Q1 2020 $13.8 M Jan 1, 2020 Mar 31, 2020 10-K 2022-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.